{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [["2K1C hypertension", "Atorvastatin", "Endothelial dysfunction", "Nitric oxide", "Nitrite", "Oxidative stress", "Sildenafil"]], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "24363994", "DateCompleted": {"Year": "2015", "Month": "05", "Day": "13"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "21"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1016/j.redox.2013.11.004"], "ArticleDate": [{"Year": "2013", "Month": "11", "Day": "17"}], "Journal": {"ISSN": "2213-2317", "JournalIssue": {"Volume": "1", "Issue": "1", "PubDate": {"Year": "2013"}}, "Title": "Redox biology", "ISOAbbreviation": "Redox Biol"}, "ArticleTitle": "Atorvastatin and sildenafil lower blood pressure and improve endothelial dysfunction, but only atorvastatin increases vascular stores of nitric oxide in hypertension.", "Pagination": {"StartPage": "578", "EndPage": "585", "MedlinePgn": "578-85"}, "Abstract": {"AbstractText": ["Nitric oxide (NO)-derived metabolites including the anion nitrite can recycle back to NO and thus complement NO formation independent of NO synthases. While nitrite is as a major vascular storage pool and source of NO, little is known about drugs that increase tissue nitrite concentrations. This study examined the effects of atorvastatin or sildenafil, or the combination, on vascular nitrite concentrations and on endothelial dysfunction in the 2 kidney-1 clip (2K1C) hypertension model. Sham-operated or 2K1C hypertensive rats were treated with vehicle, atorvastatin (50\u00a0mg/Kg), sildenafil (45\u00a0mg/Kg), or both for 8 weeks. Systolic blood pressure (SBP) was monitored weekly. Nitrite concentrations were assessed in the aortas and in plasma samples by ozone-based reductive chemiluminescence assay. Aortic rings were isolated to assess endothelium-dependent and independent relaxation. Aortic NADPH activity and ROS production were evaluated by luminescence and dihydroethidium, respectively, and plasma TBARS levels were measured. Aortic nitrotyrosine staining was evaluated to assess peroxynitrite formation. Atorvastatin and sildenafil, alone or combined, significantly lowered SBP by approximately 40\u00a0mmHg. Atorvastatin significantly increased vascular nitrite levels by 70% in hypertensive rats, whereas sildenafil had no effects. Both drugs significantly improved the vascular function, and decreased vascular NADPH activity, ROS, and nitrotyrosine levels. Lower plasma TBARS concentrations were found with both treatments. The combination of drugs showed no improved responses compared to each drug alone. These findings show evidence that atorvastatin, but not sildenafil, increases vascular NO stores, although both drugs exert antioxidant effects, improve endothelial function, and lower blood pressure in 2K1C hypertension."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Av. Bandeirantes 3900, Ribeirao Preto 14049-900, SP, Brazil."}], "Identifier": [], "LastName": "Guimar\u00e3es", "ForeName": "Danielle A", "Initials": "DA"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Av. Bandeirantes 3900, Ribeirao Preto 14049-900, SP, Brazil."}], "Identifier": [], "LastName": "Rizzi", "ForeName": "Elen", "Initials": "E"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Av. Bandeirantes 3900, Ribeirao Preto 14049-900, SP, Brazil."}], "Identifier": [], "LastName": "Ceron", "ForeName": "Carla S", "Initials": "CS"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Av. Bandeirantes 3900, Ribeirao Preto 14049-900, SP, Brazil."}], "Identifier": [], "LastName": "Pinheiro", "ForeName": "Lucas C", "Initials": "LC"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Morphology, Physiology, and Basic Pathology, University of Sao Paulo, s/n Av. Caf\u00e9, Ribeirao Preto 14040-904, SP, Brazil."}], "Identifier": [], "LastName": "Gerlach", "ForeName": "Raquel F", "Initials": "RF"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Av. Bandeirantes 3900, Ribeirao Preto 14049-900, SP, Brazil."}], "Identifier": [], "LastName": "Tanus-Santos", "ForeName": "Jose E", "Initials": "JE"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Redox Biol", "NlmUniqueID": "101605639", "ISSNLinking": "2213-2317"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Heptanoic Acids"}, {"RegistryNumber": "0", "NameOfSubstance": "Piperazines"}, {"RegistryNumber": "0", "NameOfSubstance": "Purines"}, {"RegistryNumber": "0", "NameOfSubstance": "Pyrroles"}, {"RegistryNumber": "0", "NameOfSubstance": "Sulfonamides"}, {"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}, {"RegistryNumber": "A0JWA85V8F", "NameOfSubstance": "Atorvastatin"}, {"RegistryNumber": "BW9B0ZE037", "NameOfSubstance": "Sildenafil Citrate"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism", "pathology"], "DescriptorName": "Aorta"}, {"QualifierName": [], "DescriptorName": "Atorvastatin"}, {"QualifierName": ["drug effects"], "DescriptorName": "Blood Pressure"}, {"QualifierName": ["drug effects"], "DescriptorName": "Body Weight"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Drug Therapy, Combination"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Heptanoic Acids"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Hypertension, Renovascular"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["blood", "metabolism"], "DescriptorName": "Nitric Oxide"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Piperazines"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Purines"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Pyrroles"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}, {"QualifierName": [], "DescriptorName": "Sildenafil Citrate"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Sulfonamides"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 1993;329:2002\u20132012.", "ArticleIdList": ["7504210"]}, {"Citation": "Thomas G.D., Zhang W., Victor R.G. Nitric oxide deficiency as a cause of clinical hypertension: promising new drug targets for refractory hypertension. J. Am. Med. Assoc. 2001;285:2055\u20132057.", "ArticleIdList": ["11311074"]}, {"Citation": "Ghiadoni L., Taddei S., Virdis A. Hypertension and endothelial dysfunction: therapeutic approach. Curr. Vasc. Pharmacol. 2012;10:42\u201360.", "ArticleIdList": ["22112351"]}, {"Citation": "Gladwin M.T., Schechter A.N., Kim-Shapiro D.B., Patel R.P., Hogg N., Shiva S., Cannon R.O., 3rd, Kelm M., Wink D.A., Espey M.G., Oldfield E.H., Pluta R.M., Freeman B.A., Lancaster J.R., Jr., Feelisch M., Lundberg J.O. The emerging biology of the nitrite anion. Nat. Chem. Biol. 2005;1:308\u2013314.", "ArticleIdList": ["16408064"]}, {"Citation": "Lundberg J.O., Gladwin M.T., Ahluwalia A., Benjamin N., Bryan N.S., Butler A., Cabrales P., Fago A., Feelisch M., Ford P.C., Freeman B.A., Frenneaux M., Friedman J., Kelm M., Kevil C.G., Kim-Shapiro D.B., Kozlov A.V., Lancaster J.R., Jr, Lefer D.J., McColl K., McCurry K., Patel R.P., Petersson J., Rassaf T., Reutov V.P., Richter-Addo G.B., Schechter A., Shiva S., Tsuchiya K., van Faassen E.E., Webb A.J., Zuckerbraun B.S., Zweier J.L., Weitzberg E. Nitrate and nitrite in biology, nutrition and therapeutics. Nat. Chem. Biol. 2009;5:865\u2013869.", "ArticleIdList": ["PMC4038383", "19915529"]}, {"Citation": "Cosby K., Partovi K.S., Crawford J.H., Patel R.P., Reiter C.D., Martyr S., Yang B.K., Waclawiw M.A., Zalos G., Xu X., Huang K.T., Shields H., Kim-Shapiro D.B., Schechter A.N., Cannon R.O., 3rd, Gladwin M.T. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat. Med. 2003;9:1498\u20131505.", "ArticleIdList": ["14595407"]}, {"Citation": "Li H., Cui H., Kundu T.K., Alzawahra W., Zweier J.L. Nitric oxide production from nitrite occurs primarily in tissues not in the blood: critical role of xanthine oxidase and aldehyde oxidase. J. Biol. Chem. 2008;283:17855\u201317863.", "ArticleIdList": ["PMC2440597", "18424432"]}, {"Citation": "Shiva S. Nitrite: a physiological store of nitric oxide and modulator of mitochondrial function. Redox Biol. 2013;1:40\u201344.", "ArticleIdList": ["PMC3661298", "23710434"]}, {"Citation": "Touyz R.M., Briones A.M. Reactive oxygen species and vascular biology: implications in human hypertension. Hypertens. Res. 2011;34:5\u201314.", "ArticleIdList": ["20981034"]}, {"Citation": "Cai H., Griendling K.K., Harrison D.G. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol. Sci. 2003;24:471\u2013478.", "ArticleIdList": ["12967772"]}, {"Citation": "Castro M.M., Rizzi E., Figueiredo-Lopes L., Fernandes K., Bendhack L.M., Pitol D.L., Gerlach R.F., Tanus-Santos J.E. Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats. Atherosclerosis. 2008;198:320\u2013331.", "ArticleIdList": ["18054360"]}, {"Citation": "Castro M.M., Rizzi E., Rodrigues G.J., Ceron C.S., Bendhack L.M., Gerlach R.F., Tanus-Santos J.E. Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension. Free Radic. Biol. Med. 2009;46:1298\u20131307.", "ArticleIdList": ["19248829"]}, {"Citation": "Endres M., Laufs U. Effects of statins on endothelium and signaling mechanisms. Stroke. 2004;35:2708\u20132711.", "ArticleIdList": ["15375300"]}, {"Citation": "Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation. 2004;109:III39\u2013III43.", "ArticleIdList": ["15198965"]}, {"Citation": "Vlachopoulos C., Ioakeimidis N., Rokkas K., Stefanadis C. Cardiovascular effects of phosphodiesterase type 5 inhibitors. J. Sex. Med. 2009;6:658\u2013674.", "ArticleIdList": ["19138362"]}, {"Citation": "Dias-Junior C.A., Souza-Costa D.C., Zerbini T., da Rocha J.B., Gerlach R.F., Tanus-Santos J.E. The effect of sildenafil on pulmonary embolism-induced oxidative stress and pulmonary hypertension. Anesth. Analg. 2005;101:115\u2013120.", "ArticleIdList": ["15976216"]}, {"Citation": "Tanus-Santos J.E. Antioxidant effects of phosphodiesterase-5 inhibitors. Cardiovasc. Res. 2013;100:170.", "ArticleIdList": ["23901072"]}, {"Citation": "Wang Q.M., Wei Y., Zheng Y., Waeber C. Efficacy of combined atorvastatin and sildenafil in promoting recovery after ischemic stroke in mice. Am. J. Phys. Med. Rehabil. 2013;92:143\u2013150.", "ArticleIdList": ["PMC3675160", "22854903"]}, {"Citation": "Castro M.M., Rizzi E., Rascado R.R., Nagassaki S., Bendhack L.M., Tanus-Santos J.E. Atorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanisms. Eur. J. Pharmacol. 2004;498:189\u2013194.", "ArticleIdList": ["15363994"]}, {"Citation": "Neto-Neves E.M., Dias-Junior C.A., Uzuelli J.A., Pereira R.P., Spiller F., Czaikoski P.G., Tanus-Santos J.E. Sildenafil improves the beneficial hemodynamic effects exerted by atorvastatin during acute pulmonary thromboembolism. Eur. J. Pharmacol. 2011;670:554\u2013560.", "ArticleIdList": ["21946107"]}, {"Citation": "Wassmann S., Laufs U., Baumer A.T., Muller K., Ahlbory K., Linz W., Itter G., Rosen R., Bohm M., Nickenig G. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species. Hypertension. 2001;37:1450\u20131457.", "ArticleIdList": ["11408394"]}, {"Citation": "Ferreira-Melo S.E., Yugar-Toledo J.C., Coelho O.R., De Luca I.M., Tanus-Santos J.E., Hyslop S., Irigoyen M.C., Moreno H., Jr. Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats. Eur. J. Pharmacol. 2006;542:141\u2013147.", "ArticleIdList": ["16806160"]}, {"Citation": "Feelisch M., Rassaf T., Mnaimneh S., Singh N., Bryan N.S., Jourd'Heuil D., Kelm M. Concomitant S-, N-, and heme-nitros(yl)ation in biological tissues and fluids: implications for the fate of NO in vivo. FASEB J. 2002;16:1775\u20131785.", "ArticleIdList": ["12409320"]}, {"Citation": "Bryan N.S., Rassaf T., Maloney R.E., Rodriguez C.M., Saijo F., Rodriguez J.R., Feelisch M. Cellular targets and mechanisms of nitros(yl)ation: an insight into their nature and kinetics in vivo. Proc. Natl. Acad. Sci. USA. 2004;101:4308\u20134313.", "ArticleIdList": ["PMC384737", "15014175"]}, {"Citation": "Cau S.B., Guimaraes D.A., Rizzi E., Ceron C.S., Souza L.L., Tirapelli C.R., Gerlach R.F., Tanus-Santos J.E. Pyrrolidine dithiocarbamate down-regulates vascular matrix metalloproteinases and ameliorates vascular dysfunction and remodelling in renovascular hypertension. Br. J. Pharmacol. 2011;164:372\u2013381.", "ArticleIdList": ["PMC3174417", "21434884"]}, {"Citation": "Ceron C.S., Castro M.M., Rizzi E., Montenegro M.F., Fontana V., Salgado M.C., Gerlach R.F., Tanus-Santos J.E. Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension. Br. J. Pharmacol. 2010;160:77\u201387.", "ArticleIdList": ["PMC2860208", "20331602"]}, {"Citation": "Montenegro M.F., Pinheiro L.C., Amaral J.H., Marcal D.M., Palei A.C., Costa-Filho A.J., Tanus-Santos J.E. Antihypertensive and antioxidant effects of a single daily dose of sodium nitrite in a model of renovascular hypertension. Naunyn Schmiedebergs Arch. Pharmacol. 2012;385:509\u2013517.", "ArticleIdList": ["22262021"]}, {"Citation": "Prado C.M., Rossi M.A. Circumferential wall tension due to hypertension plays a pivotal role in aorta remodelling. Int. J. Exp. Pathol. 2006;87:425\u2013436.", "ArticleIdList": ["PMC2517390", "17222210"]}, {"Citation": "Harrison D.G., Gongora M.C., Guzik T.J., Widder J. Oxidative stress and hypertension. J. Am. Soc. Hypertens. 2007;1:30\u201344.", "ArticleIdList": ["20409831"]}, {"Citation": "Jung O., Schreiber J.G., Geiger H., Pedrazzini T., Busse R., Brandes R.P. gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension. Circulation. 2004;109:1795\u20131801.", "ArticleIdList": ["15037533"]}, {"Citation": "Yaguas K., Bautista R., Quiroz Y., Ferrebuz A., Pons H., Franco M., Vaziri N.D., Rodriguez-Iturbe B. Chronic sildenafil treatment corrects endothelial dysfunction and improves hypertension. Am. J. Nephrol. 2010;31:283\u2013291.", "ArticleIdList": ["20110668"]}, {"Citation": "Gladwin M.T., Raat N.J., Shiva S., Dezfulian C., Hogg N., Kim-Shapiro D.B., Patel R.P. Nitrite as a vascular endocrine nitric oxide reservoir that contributes to hypoxic signaling, cytoprotection, and vasodilation. Am. J. Physiol. Heart Circ. Physiol. 2006;291:H2026\u2013H2035.", "ArticleIdList": ["16798825"]}, {"Citation": "Gladwin M.T., Crawford J.H., Patel R.P. The biochemistry of nitric oxide, nitrite, and hemoglobin: role in blood flow regulation. Free Radic. Biol. Med. 2004;36:707\u2013717.", "ArticleIdList": ["14990351"]}, {"Citation": "Kleinbongard P., Dejam A., Lauer T., Jax T., Kerber S., Gharini P., Balzer J., Zotz R.B., Scharf R.E., Willers R., Schechter A.N., Feelisch M., Kelm M. Plasma nitrite concentrations reflect the degree of endothelial dysfunction in humans. Free Radic. Biol. Med. 2006;40:295\u2013302.", "ArticleIdList": ["16413411"]}, {"Citation": "Zweier J.L., Li H., Samouilov A., Liu X. Mechanisms of nitrite reduction to nitric oxide in the heart and vessel wall. Nitric Oxide. 2010;22:83\u201390.", "ArticleIdList": ["PMC2851168", "20044016"]}, {"Citation": "Martins-Oliveira A., Castro M.M., Oliveira D.M., Rizzi E., Ceron C.S., Guimaraes D., Reis R.I., Costa-Neto C.M., Casarini D.E., Ribeiro A.A., Gerlach R.F., Tanus-Santos J.E. Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling. Int. J. Cardiol. 2013;167:1199\u20131205.", "ArticleIdList": ["22483258"]}, {"Citation": "Ceron C.S., Rizzi E., Guimaraes D.A., Martins-Oliveira A., Cau S.B., Ramos J., Gerlach R.F., Tanus-Santos J.E. Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertension. Matrix Biol. 2012;31:261\u2013270.", "ArticleIdList": ["22342460"]}, {"Citation": "Montenegro M.F., Amaral J.H., Pinheiro L.C., Sakamoto E.K., Ferreira G.C., Reis R.I., Marcal D.M., Pereira R.P., Tanus-Santos J.E. Sodium nitrite downregulates vascular NADPH oxidase and exerts antihypertensive effects in hypertension. Free Radic. Biol. Med. 2011;51:144\u2013152.", "ArticleIdList": ["21530643"]}, {"Citation": "Montenegro M.F., Neto-Neves E.M., Dias-Junior C.A., Ceron C.S., Castro M.M., Gomes V.A., Kanashiro A., Tanus-Santos J.E. Quercetin restores plasma nitrite and nitroso species levels in renovascular hypertension. Naunyn Schmiedebergs Arch. Pharmacol. 2010;382:293\u2013301.", "ArticleIdList": ["20694791"]}, {"Citation": "Alef M.J., Vallabhaneni R., Carchman E., Morris S.M., Jr, Shiva S., Wang Y., Kelley E.E., Tarpey M.M., Gladwin M.T., Tzeng E., Zuckerbraun B.S., Nitrite-generated N.O. circumvents dysregulated arginine/NOS signaling to protect against intimal hyperplasia in Sprague-Dawley rats. J. Clin. Invest. 2011;121:1646\u20131656.", "ArticleIdList": ["PMC3069768", "21436585"]}]}], "History": [{"Year": "2013", "Month": "11", "Day": "5"}, {"Year": "2013", "Month": "11", "Day": "8"}, {"Year": "2013", "Month": "11", "Day": "11"}, {"Year": "2013", "Month": "12", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2013", "Month": "12", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2013", "Month": "12", "Day": "24", "Hour": "6", "Minute": "1"}, {"Year": "2013", "Month": "11", "Day": "17"}], "PublicationStatus": "epublish", "ArticleIdList": ["24363994", "PMC3863772", "10.1016/j.redox.2013.11.004", "S2213-2317(13)00084-0"]}}], "PubmedBookArticle": []}